Changes in and partial identification of the plasminogen activator and plasminogen activator inhibitor systems during ovarian follicular maturation in the pig.
Plasminogen, plasmin, and plasminogen activator (PA) activities and PA and PA inhibitor (PAI) contents were measured in granulosa (GC) and theca interna cell extracts and follicular fluid (FF) obtained from preovulatory follicles of prepubertal gilts treated with eCG and hCG to induce follicular growth and ovulation. Plasmin activity in FF increased just before the time of expected ovulation. This increase was not attributable to changes in plasminogen levels, which remained relatively constant during preovulatory follicular development. The increase in follicular plasmin levels was associated with significant (p less than 0.01) increases in PA activity and content and decreases in PAI content in GC and FF. Western blot analysis suggested that follicular PA activity was represented principally by two forms of tissue type PA (t-PA) each with a pI of 7.8 and with molecular masses of 72,000 and 78,000 daltons, respectively. Two PA-PAI complexes of 126,000 and 130,000 daltons were observed. These complexes were partially dissociated with nucleophilic agents into two t-PA-like forms and a 52,000-dalton PAI protein with a pI of 4.8. Biochemical characteristics of the PAI protein suggest that it belongs to the same class of inhibitors as bovine and human PAI-1. These data indicate that rupture of the porcine ovarian follicle is temporally associated with a net increase in PA activity and an increase in plasmin activity. The increase in PA activity appears to be regulated by changes in PA and PAI content.
Politis
I
I
Department of Animal Science, Macdonald College of McGill University, Ste. Anne de Bellevue, Quebec, Canada.
Srikandakumar
A
A
Turner
J D
JD
Tsang
B K
BK
Ainsworth
L
L
Downey
B R
BR
D000818:Animals; D015153:Blotting, Western; D002457:Cell Extracts / Q000032:analysis; D006063:Chorionic Gonadotropin / Q000494:pharmacology; D005260:Female; D005341:Fibrinolysin / Q000032:analysis / Q000378:metabolism; D015571:Follicular Fluid / Q000737:chemistry / Q000378:metabolism; D006064:Gonadotropins, Equine / Q000494:pharmacology; D006107:Granulosa Cells / Q000737:chemistry / Q000187:drug effects / Q000378:metabolism; D007150:Immunohistochemistry; D006080:Ovarian Follicle / Q000166:cytology / Q000187:drug effects / Q000502:physiology*; D010960:Plasminogen Activators / Q000032:analysis / Q000378:metabolism / Q000502:physiology*; D015849:Plasminogen Inactivators / Q000032:analysis / Q000378:metabolism / Q000494:pharmacology*; D013552:Swine / Q000502:physiology*; D013799:Theca Cells / Q000737:chemistry / Q000187:drug effects / Q000378:metabolism
D002457:Cell Extracts; D006063:Chorionic Gonadotropin; D006064:Gonadotropins, Equine; D015849:Plasminogen Inactivators; D010960:Plasminogen Activators; D005341:Fibrinolysin